TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.
LP0162-2328
Approved small_molecule active
Quick answer
TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP. for Atopic dermatitis and moderate-to severe atopic hand eczema is a Approved program (small_molecule) at LEO Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEO Pharma A/S
- Indication
- Atopic dermatitis and moderate-to severe atopic hand eczema
- Phase
- Approved
- Modality
- small_molecule
- Status
- active